Asset Details
Do you wish to reserve the book?
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Do you wish to request the book?
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Polypill for Cardiovascular Disease Prevention in an Underserved Population
2019
Overview
Participants in an underserved minority population in the United States were randomly assigned to receive a polypill that included low doses of atorvastatin, amlodipine, losartan, and hydrochlorothiazide or to receive usual care. At 12 months, systolic blood pressure and LDL cholesterol levels were significantly lower in the polypill group.
Publisher
Massachusetts Medical Society
Subject
/ Alabama
/ Amlodipine - administration & dosage
/ Antihypertensive Agents - administration & dosage
/ Atorvastatin - administration & dosage
/ Female
/ Humans
/ Hydrochlorothiazide - administration & dosage
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage
/ Hypercholesterolemia - blood
/ Hypercholesterolemia - complications
/ Hypercholesterolemia - drug therapy
/ Hypertension - complications
/ Losartan - administration & dosage
/ Male
